SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-007283
Filing Date
2024-01-26
Accepted
2024-01-26 16:27:10
Documents
7
Period of Report
2024-03-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm242571-1_def14a.htm DEF 14A 1101625
2 GRAPHIC bc_netloss-4clr.jpg GRAPHIC 144721
3 GRAPHIC bc_tsr-4clr.jpg GRAPHIC 181933
4 GRAPHIC lg_essa-4c.jpg GRAPHIC 18651
5 GRAPHIC lg_laurelhilladvgrp-4c.jpg GRAPHIC 47476
6 GRAPHIC px_24essaproxy01page01-4c.jpg GRAPHIC 373723
7 GRAPHIC px_24essaproxy01page02-bw.jpg GRAPHIC 304806
  Complete submission text file 0001104659-24-007283.txt   2524931
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-37410 | Film No.: 24568288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)